ArticleJournal for immunotherapy of cancer2023

ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer.

Huanhuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.